關於 cookie 的說明

本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗,我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示,便表示您已接受我們的網站使用條款。

搜尋結果Search Result

符合「New products/services」新聞搜尋結果, 共 552 篇 ,以下為 217 - 240 篇 訂閱此列表,掌握最新動態
Yili Group Kicks Off 2026 with Strategic Partner Conferences in Southeast Asia

BANGKOK and BANDUNG, Indonesia, Jan. 28, 2026 /PRNewswire/ --  As the new year begins, Yili Group continues to build momentum in Southeast Asia. Recently, Yili's subsidiaries in Thailand and Indonesia successfully held their 2026 Top Partners Conferences in Bangkok and Bandung, respectively. The events gathered over 120 partners in Bangkok and 263 partners in Bandung from Indonesia, Vietnam, the Philippines, and beyond to celebrate collaboration and explore new opportunities for mutual growth. As Yili deepens its global footprint, the company is advancing steadily across Southeast Asia and the world, working together with partners to shape the future of the international dairy industry. 2026 Top Partners Conference of Yili’s Indonesian Subsidiary   2026 Top Partners Conference of Yili’s Thai Subsidiary Localization Strategy Delivers Results In 2025, despite a complex global environment and intensifying competition, Yili remained committed to its localization strategy and delivered impressive results. In Indonesia, Joyday ice cream achieved another breakthrough, becoming the only brand in the local industry to see growth in purchase conversion. In Thailand, Cremo ice cream continued to expand its market share and brand recognition, making significant strides in brand building, product innovation, channel expansion, and corporate social responsibility. Unveiling Innovative New Products Guided by the philosophy "No Innovation, No Future," Yili leveraged deep insights into local consumer trends to develop a range of new products, which were officially unveiled at the conferences. The new lineup received high praise from distributors for their rich flavor, innovative designs, and eye-catching packaging. One distributor commented, "Yili always has a precise grasp of consumer needs. These new products maintain the brand's standard of excellence while achieving breakthroughs in flavor and versatility. We are confident they will achieve great market success!" Embarking on a New Journey with Partners During the conferences, Yili expressed sincere gratitude to its long-term partners and recognized outstanding distributors with awards. From the launch of Joyday in Indonesia to the revitalization of Cremo in Thailand, Yili has built a strong foundation of mutual trust with Southeast Asian partners. At the Bandung event, a long-term partner noted, "After seven years of collaboration, Yili has proven that when we stand together, anything is possible." Similarly, at the Thailand conference, a distributor shared, "Collaborating with Yili in 2025 has been a rewarding, win-win experience. Their high-quality products, targeted marketing, and comprehensive support have continuously strengthened our competitiveness in the local market." Yili Group remains dedicated to expanding its presence in Southeast Asia and beyond. By strengthening brands, optimizing products, expanding channels, and consolidating infrastructure, Yili will continue to work with global partners to build a "Global Health Ecosystem," delivering higher-quality and more diverse health products to consumers worldwide.

文章來源 : PR Newswire 美通社 發表時間 : 瀏覽次數 : 243 加入收藏 :
GAC AION V Secures 5-Star ANCAP Safety Rating Upon Launch in Australia and New Zealand, Demonstrating the Safety Strength of Chinese Brands

SYDNEY, Jan. 28, 2026 /PRNewswire/ -- In November 2025, GAC AION V officially launched in Australia and New Zealand, and simultaneously obtained the 5-star safety rating from the Australasian New Car Assessment Program (ANCAP). This rating applies to all AION V variants produced since September 2025, with a validity period until December 2031. ANCAP safety rating focuses on four core dimensions: Adult Occupant Protection, Child Occupant Protection, Vulnerable Road User Protection, and Safety Assist. With extremely rigorous testing processes and internationally advanced evaluation standards, it comprehensively assesses the overall safety performance of vehicles. GAC AION V has demonstrated balanced and outstanding performance in all dimensions, successfully securing the 5-star certification — Adult Occupant Protection reaches a high level, Child Occupant Protection performs brilliantly, while Vulnerable Road User Protection and Safety Assist systems show steady performance, achieving all-scenario safety protection without shortcomings. AION V performed brilliantly in core crash tests. In scenarios such as frontal offset collision and side collision, it provided excellent protection for key body parts of occupants, and even achieved full marks in the side collision test. In the Child Occupant Protection dimension, AION V achieved full marks in both frontal and side collision dynamic tests, providing excellent protection for key body parts of 6-year-old and 10-year-old child dummies. AION V enhances passive protection through optimized body structure, and most areas of the bonnet provide excellent protection for pedestrians' heads. The model is equipped with a full set of standard intelligent safety assist configurations. As an important model launched by GAC in the Australian and New Zealand markets, AION V's acquisition of the 5-star ANCAP safety rating this time is not only an authoritative recognition of the model's own safety design and configuration, but also demonstrates the strong strength of Chinese brands in the field of vehicle safety. GAC has always taken safety as the core of product research and development, and continuously creates safe and reliable travel vehicles for global consumers through body structure optimization, safety configuration upgrading, and intelligent safety system iteration.

文章來源 : PR Newswire 美通社 發表時間 : 瀏覽次數 : 206 加入收藏 :
EDUCATION IN MOTION LAUNCHES GROUP-WIDE AI IN EDUCATION INITIATIVE TO COMBINE INNOVATION WITH ACADEMIC RIGOUR

Groundbreaking programme will deliver a scalable AI framework, school-based research pilots, teacher playbooks, and ethical governance integrated with EiM's digital ecosystem to support students in an AI world. SINGAPORE, Jan. 28, 2026 /PRNewswire/ -- Education in Motion (EiM), a global leader in pioneering educational excellence, today announced a new AI in education initiative in partnership with Dr Rose Luckin, Professor Emeritus at University College London, world-renowned expert on AI use in education. Led by EiM's Chief Innovation Officer Crispian Farrow and supported by Professor Rose Luckin's consultancy Educate Ventures Research, which aims to help organisations leverage AI, this initiative builds on EiM's existing digital ecosystem to pilot new use cases designed to more deeply understand the impact of AI on teaching and learning. These cases will not only look at effectively applying new technology in curriculum, but also clarify the strategic purpose behind such integration: advancing human-centred learning, ethical practice, and academic rigour in the age of AI. Taken together, these measures will enable students, staff and the wider community to work with tools augmented by AI ensuring responsible, safe and equitable use. Through real-world, in-school application, the programme will deliver a scalable AI framework for all EiM schools – which includes the network of Dulwich College International schools; an enhanced understanding of how to best apply AI in education approaches; a practical, research-based AI playbook for teachers; and an age-differentiated curriculum designed for AI literacy and mastery, while cultivating critical thinking. "AI is moving fast, but excellence demands discernment," said Lesley Meyer, Chief Education Officer at EiM. "Our aim is not to chase tools, but to strengthen the human heart of education — critical thinking, creativity, empathy — while holding firm to academic standards. This initiative ensures AI serves teaching, integrity, and student wellbeing." "This is an operational roadmap with guardrails," said Crispian Farrow, Chief Innovation Officer at EiM. "By combining school-based research pilots, rigorous evaluation of impact, and an evidence-based AI playbook for teachers, we'll further integrate AI with our ecosystem in ways that are secure, compliant, and demonstrably valuable. Every school will contribute evidence so we can scale what works and avoid what doesn't." "I am truly impressed by what I have seen at EiM so far: it has already understood that effective AI in education must be ethical, evidence-informed, and focused on learning," said Professor Rose Luckin. "We will build a framework that tests assumptions, measures impact and supports teachers — refining an approach that is rigorous, equitable and scalable," added Dr Madiha Khan, Director of Research & Consultancy at Educate Ventures Research. Phase one includes teacher competency development in the digital domain, an AI critical thinking framework across age bands, data and impact-evaluation protocols, and monthly consultation clinics to support implementation. Dr Luckin is also a member of the EiM Education Advisory Board, announced in September, which will provide additional insight and oversight. "We are assembling a range of world leading assets to help us shape the future of learning" added Meyer. "EiM has the vision, infrastructure and values to lead the sector, and by drawing on resources like the expertise of our Education Advisory Boardwe are preparing young people to thrive in an AI-shaped world by combining bold innovation with academic rigour and ethical purpose." About Education in Motion Education in Motion (EiM) is a global leader in pioneering educational excellence, inspiring generations of learners to Live Worldwise. Since the founding of its first school over two decades ago, EiM has grown its diverse portfolio of schools and brands, offering a blend of innovation and tradition through a range of premium educational offerings across the globe. These include Dulwich College International, which offers both K-12 schools and a High School Programme; Dehong®, offering bilingual education; Green School International, promoting sustainability across Bali and the world; Sherfield School in the United Kingdom; Hochalpines Institut Ftan AG (HIF) in Switzerland; Ignite, a unique outdoors-based overseas residential programme; and Chinese-language learning and teaching platform Wo Hui Mandarin. Today, EiM empowers over 11,500 students across 15 schools worldwide to thrive holistically on tailored pathways for each unique individual, resulting in outstanding academic results and top university matriculation. For more information about EiM and its brands, visit www.eimglobal.com.

文章來源 : PR Newswire 美通社 發表時間 : 瀏覽次數 : 237 加入收藏 :
Polyplastics Develops New DURAFIDE(R) PPS Grades with Mechanically Recycled Content

TOKYO, Jan. 28, 2026 /PRNewswire/ -- Polyplastics Co., Ltd., a global leader in engineering thermoplastics, has developed two new DURAFIDE(R) polyphenylene sulfide (PPS) grades made of mechanically recycled content. The 40% glass fiber-reinforced grades, DURAFIDE(R) rG-PPS 1140A1R00 and 1140A1R30 (with 100% and 30% recycled glass fiber-reinforced PPS content, respectively), are set for launch in the next few months. Image: https://cdn.kyodonewsprwire.jp/prwfile/release/M100475/202601202736/_prw_PI1fl_5M5BC94J.jpg The new offering is part of Polyplastics' DURACIRCLE(R) initiative, which strives to achieve 100% circularity for engineering plastics. These new grades are offered through the company's re-compounding service, which utilizes process scrap collected from customers as raw material under its "Open PIR Mechanical Recycling Scheme." High-quality product manufacturing is achieved by collecting glass fiber-reinforced PPS process scrap from partner companies meeting high standards. After rigorous inspection, sorting, and reformulation, the materials are compounded under optimal conditions and undergo the same quality assurance as virgin materials. Polyplastics will sell these materials through its global sales network. Currently, collection targets are limited to specific grades of glass-filled DURAFIDE(R) PPS materials. For the re-compounding business and the establishment of the "Open PIR Mechanical Recycling Scheme," developing new applications and securing collection routes are essential. The company is targeting initiatives that envision collaboration not only with existing customers but also with companies in various waste-to-value industries. Polyplastics is exploring adding new mechanically recycled PPS grades to its lineup in response to market needs. The goal is to build self-contained "local production for local consumption" recycling chains within each country and region worldwide. Simultaneously, by expanding the range of constituent materials to include PCR materials, Polyplastics will enhance its supply capacity for high-quality, reliable recycled materials. This will further reduce environmental impact and enhance the ability to meet customers' diverse needs. For more information, visit: https://www.polyplastics.com/global/s/ourapproach/a5nRB000001nik7YAA/225?language=en_US About Polyplastics Polyplastics Co., Ltd. is a global leader in the development and production of engineering thermoplastics. The company's product portfolio includes POM, PBT, PPS, LCP, PET, COC, and LFT, with global-leading market share for POM, LCP, and COC. With more than 60 years of experience, the company is backed by a strong global network of R&D, production, and sales resources capable of creating advanced solutions for an ever-changing global marketplace. DURAFIDE(R) and DURACIRCLE(R) are registered trademarks of Polyplastics Co., Ltd. in Japan and other countries.

文章來源 : PR Newswire 美通社 發表時間 : 瀏覽次數 : 211 加入收藏 :
Hanmi Secures Export Deal with Mexican Partner Sanfer for GLP-1 Obesity Drug and More

Hanmi Signs Exclusive Partnership with New Mexican Partner Laboratorios Sanfer, Covering Efpeglenatide and Diabetes Treatments  SEOUL, South Korea, Jan. 28, 2026 /PRNewswire/ -- Hanmi is accelerating its global market entry with efpeglenatide, Korea's first domestically developed GLP-1 class obesity and metabolic disease treatment. Hanmi Pharmaceutical, the core operating company of Hanmi Science, announced on January 28 that it has signed an exclusive distribution agreement with Mexican pharmaceutical company Laboratorios Sanfer for efpeglenatide, its GLP-1 obesity therapy, as well as the Dapalon Family, Hanmi's flagship diabetes treatment portfolio (Dapalon Tab. and Dapalon Duo SR Tab.). Under the agreement, Hanmi will supply efpeglenatide and the Dapalon Family, while Laboratorios Sanfer will be responsible for regulatory approval, marketing, distribution, and sales within Mexico. Mexico is one of the countries with the highest obesity rates globally, with obesity prevalence reaching 36.86%, while diabetes prevalence stands at 16.4%.[1] As demand in the market extends beyond weight loss and maintenance therapy to include blood glucose management, the agreement reflects confidence in efpeglenatide's global scalability and strategic value. Founded in 1941, Sanfer is Mexico's largest privately held pharmaceutical company. Leveraging its extensive sales and distribution network across Latin America and its in-house R&D capabilities, Sanfer has established itself as a leading pharmaceutical company in the region. The company operates in more than 20 countries across Latin America as well as in the United States and recently strengthened its position as Mexico's largest biopharmaceutical company through the acquisition of Probiomed. The partnership is expected to gradually expand collaboration across efpeglenatide and other metabolic disease treatments, including additional product launches and joint marketing strategies over the mid- to long term. Ricardo Amtmann, CEO of Sanfer, stated, "As a leading pharmaceutical company in Mexico and Latin America, our vision is to improve patients' lives through innovative, high-quality products. With healthcare costs accounting for 34.6% of household spending in Mexico, improving accessibility to innovative treatments is critical.[2] Hanmi's efpeglenatide and diabetes treatment portfolio meet these needs." He added, "Through this partnership, we aim to contribute to addressing the rapidly growing challenges of obesity and diabetes in Mexico." Jae-hyun Park, CEO of Hanmi Pharmaceutical, said, "This agreement marks an important milestone that demonstrates Hanmi's formulation capabilities and R&D competitiveness on the global stage. As the Mexican government places greater emphasis on standardizing healthcare services and strengthening the management of chronic diseases, we find it especially meaningful that Hanmi's independently developed, Korea's first GLP-1–based obesity and metabolic disease treatment, together with our innovative diabetes treatment portfolio, will be able to contribute to improving the health of the Mexican population." Meanwhile, Hanmi completed its regulatory application for efpeglenatide to the Ministry of Food and Drug Safety on December 17, 2025. In September 2025, the company also submitted an IND for a Phase 3 clinical trial evaluating combination therapy with SGLT-2 inhibitors and metformin, which was approved on January 21, 2026. Hanmi is pursuing an expansion of efpeglenatide's indications from obesity into diabetes, with obesity approval targeted for the second half of 2026 and an additional diabetes indication planned for 2028. Contact info: Official Websites: www.hanmipharm.com, www.linkedin.com/company/hanmipharm innovation@hanmi.co.kr, +82-02-410-0467 [1] World Obesity Federation(Global Obesity Observatory)https://data.worldobesity.org/rankings/?age=a&sex=tInternational Diabetes Federationhttps://diabetesatlas.org/data-by-location/country/mexico/ [2] Mexico Business_Health Sector Represented 5.2% of Mexico's GDP in 2024https://mexicobusiness.news/health/news/health-sector-represented-52-mexicos-gdp-2024  

文章來源 : PR Newswire 美通社 發表時間 : 瀏覽次數 : 176 加入收藏 :
2026 年 2 月 10 日 (星期二) 農曆十二月廿三日
首 頁 我的收藏 搜 尋 新聞發佈